Status:
COMPLETED
Prospective Randomized Controlled Trial for Pain Relief After Office Ureteral Stent Removal
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Pain
Urinary Stone
Eligibility:
All Genders
18-79 years
Phase:
PHASE2
Brief Summary
This is a prospective randomized double-blind controlled trial assessing the benefits of intramuscular ketorolac before or immediately after office ureteral stent removal.
Detailed Description
Patients who are undergoing cystoscopy with ureteral stent removal at the University of Texas Southwestern Medical Center and have no contraindications to receiving ketorolac will be eligible. Patient...
Eligibility Criteria
Inclusion
- patients 18 to 79 who have undergone a cystoscopy with indwelling double-J ureteral stent placement at Clements University Hospital and are presenting to the office for cystoscopy and stent removal.
Exclusion
- eGFR \<50
- any active or history of peptic ulcer disease or GI bleeding
- Bleeding disorder, suspected of confirmed cerebrovascular bleeding, hemorrhagic diathesis, or incomplete hemostasis
- Concurrent use of Aspirin 325mg, wafarin, rivaroxaban, apixaban, clopidogrel, or heparin
- Allergic reaction to NSAIDs
- Concurrent use of other NSAIDs within 24 hours
- Pregnancy (ketorolac contraindicated in this population)
- Recent myocardial infarction (MI)
Key Trial Info
Start Date :
June 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04112160
Start Date
June 28 2018
End Date
August 30 2019
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Southwestern Medical Center
Dallas, Texas, United States, 75390